Iron derivatives

For human use - including but not limited to Ferumoxytol, Iron isomaltoside 1000, Ferric carboxymaltose, Ferric maltol, i. when sold for parenteral use ii. Ferric maltol when sold for the oral treatment of iron deficiency anemia in adult patients who are unresponsive or intolerant to other oral iron preparations

Approval Date: October 4, 2024

Schedule: I

Footnote: PDL